|
Vendor News
Intas Pharma wins Animal Pharm Global Excellence Award
Vijay Teng, Vice President - Neovet, Intas Pharmaceuticals receiving the
Animal Pharm Industry Excellence Award 2007 |
Intas Pharma has won the Animal Pharm Global Excellence Awards
for the year 2007, for unique initiatives in the area of Corporate Social Responsibility
(CSR). This global accolade assumes significance, as Neovet, Intas' animal health
division, also commemorates its tenth anniversary in animal healthcare, informed
Vijay Teng, Vice-President, Neovet. Intas Neovetis currently ranks fifth in
the Indian animal healthcare market with dominance in the livestock market and
significant presence in the pet segment. The award has been presented by Animal
Pharm, an international agency dealing with world animal health and nutrition,
to celebrate innovation and to reward excellence in the animal health care sector.
The award was presented at a grand ceremony held at London, on 25th September,
2007. More than 100 top animal healthcare companies, including Janssen Animal
Health, Pfizer, Genitrix, Eurovet, Heska, Merial, Norbrook, and Schering Plough
competed globally for the awards.
The award was based on four activity spheres—Polivet Journal, Neomec Project
Shiksha, taking animal healthcare to farmer's doorstep and recognising the outstanding
contribution of veterinarians, which has benefited the animal wealth of country
and associated human resource in the last ten years. Giving further information
on these projects, Teng said that nearly 180 meritorious veterinary students
have benefited by way of scholarships under the Neomec Project Shiksha for the
last four years, while Polivet, with a free circulation of around 9,000 copies,
is meant to enhance the knowledge of veterinarians all over India. Polivet has
been recognised and indexed by many national and international agencies including
CAB. For Intas, this recognition is a big fillip to this young division, as
the company's animal health care division is still evolving, added Teng. The
award would provide Intas an impetus for all its ongoing animal healthcare development
programmes, and will motivate different pharma companies to take up such social
responsibility activities in the future, Teng concluded.
|
